N,N-dimethyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-methyl-5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyridine-2-carboxamide;N-methyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyrazin-2-amine

C119H141F3N32O13 — CID 158381264

IUPACN,N-dimethyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-methyl-5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyridine-2-carboxamide;N-methyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyrazin-2-amine
SMILESCN(C)C(=O)c1cc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)ncn1.CNC(=O)c1cc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)ncn1.CNC(=O)c1ccc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)cn1.FC(F)(F)c1cnc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)cn1.c1cc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)cnn1
InChIInChI=1S/C25H31N7O3.C25H30N6O3.C24H29N7O3.C23H25F3N6O2.C22H26N6O2/c1-31(2)25(33)21-15-23(29-16-28-21)30-17-3-5-19(6-4-17)35-22-14-18(32-9-11-34-12-10-32)13-20-24(22)27-8-7-26-20;1-26-25(32)21-7-4-18(16-29-21)30-17-2-5-20(6-3-17)34-23-15-19(31-10-12-33-13-11-31)14-22-24(23)28-9-8-27-22;1-25-24(32)20-14-22(29-15-28-20)30-16-2-4-18(5-3-16)34-21-13-17(31-8-10-33-11-9-31)12-19-23(21)27-7-6-26-19;24-23(25,26)20-13-30-21(14-29-20)31-15-1-3-17(4-2-15)34-19-12-16(32-7-9-33-10-8-32)11-18-22(19)28-6-5-27-18;1-3-19(4-2-16(1)27-17-5-6-25-26-15-17)30-21-14-18(28-9-11-29-12-10-28)13-20-22(21)24-8-7-23-20/h7-8,13-17,19H,3-6,9-12H2,1-2H3,(H,28,29,30);4,7-9,14-17,20,30H,2-3,5-6,10-13H2,1H3,(H,26,32);6-7,12-16,18H,2-5,8-11H2,1H3,(H,25,32)(H,28,29,30);5-6,11-15,17H,1-4,7-10H2,(H,30,31);5-8,13-16,19H,1-4,9-12H2,(H,25,27)
InChIKeyGVUYEHKFEIIRJW-UHFFFAOYSA-N
MW2284.64 g/mol
LogP15.34
Rot. Bonds28

About N,N-dimethyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-methyl-5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyridine-2-carboxamide;N-methyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyrazin-2-amine

N,N-dimethyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-methyl-5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyridine-2-carboxamide;N-methyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyrazin-2-amine (PubChem CID 158381264) has the molecular formula C119H141F3N32O13 and a molecular weight of 2284.64 g/mol. Its IUPAC name is N,N-dimethyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-methyl-5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyridine-2-carboxamide;N-methyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyrazin-2-amine.

Molecular Properties

Compound NameN,N-dimethyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-methyl-5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyridine-2-carboxamide;N-methyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyrazin-2-amine
PubChem CID158381264
Molecular FormulaC119H141F3N32O13
Molecular Weight2284.64 g/mol
Exact Mass2283.13
IUPAC NameN,N-dimethyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-methyl-5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyridine-2-carboxamide;N-methyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyrazin-2-amine
SMILESCN(C)C(=O)c1cc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)ncn1.CNC(=O)c1cc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)ncn1.CNC(=O)c1ccc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)cn1.FC(F)(F)c1cnc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)cn1.c1cc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)cnn1
InChIInChI=1S/C25H31N7O3.C25H30N6O3.C24H29N7O3.C23H25F3N6O2.C22H26N6O2/c1-31(2)25(33)21-15-23(29-16-28-21)30-17-3-5-19(6-4-17)35-22-14-18(32-9-11-34-12-10-32)13-20-24(22)27-8-7-26-20;1-26-25(32)21-7-4-18(16-29-21)30-17-2-5-20(6-3-17)34-23-15-19(31-10-12-33-13-11-31)14-22-24(23)28-9-8-27-22;1-25-24(32)20-14-22(29-15-28-20)30-16-2-4-18(5-3-16)34-21-13-17(31-8-10-33-11-9-31)12-19-23(21)27-7-6-26-19;24-23(25,26)20-13-30-21(14-29-20)31-15-1-3-17(4-2-15)34-19-12-16(32-7-9-33-10-8-32)11-18-22(19)28-6-5-27-18;1-3-19(4-2-16(1)27-17-5-6-25-26-15-17)30-21-14-18(28-9-11-29-12-10-28)13-20-22(21)24-8-7-23-20/h7-8,13-17,19H,3-6,9-12H2,1-2H3,(H,28,29,30);4,7-9,14-17,20,30H,2-3,5-6,10-13H2,1H3,(H,26,32);6-7,12-16,18H,2-5,8-11H2,1H3,(H,25,32)(H,28,29,30);5-6,11-15,17H,1-4,7-10H2,(H,30,31);5-8,13-16,19H,1-4,9-12H2,(H,25,27)
InChIKeyGVUYEHKFEIIRJW-UHFFFAOYSA-N
XLogP15.34
TPSA492.07 Ų
H-Bond Donors7
H-Bond Acceptors42
Rotatable Bonds28
Heavy Atoms167
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002284.64
LogP ≤ 515.34
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1042

Analyze N,N-dimethyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-methyl-5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyridine-2-carboxamide;N-methyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyrazin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N,N-dimethyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-methyl-5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyridine-2-carboxamide;N-methyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyrazin-2-amine?
The IUPAC name of N,N-dimethyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-methyl-5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyridine-2-carboxamide;N-methyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyrazin-2-amine (CID 158381264) is N,N-dimethyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-methyl-5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyridine-2-carboxamide;N-methyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyrazin-2-amine.
What is the SMILES notation for N,N-dimethyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-methyl-5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyridine-2-carboxamide;N-methyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyrazin-2-amine?
The canonical SMILES for N,N-dimethyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-methyl-5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyridine-2-carboxamide;N-methyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyrazin-2-amine is CN(C)C(=O)c1cc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)ncn1.CNC(=O)c1cc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)ncn1.CNC(=O)c1ccc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)cn1.FC(F)(F)c1cnc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)cn1.c1cc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)cnn1.
What is the InChIKey of N,N-dimethyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-methyl-5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyridine-2-carboxamide;N-methyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyrazin-2-amine?
The InChIKey is GVUYEHKFEIIRJW-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H31N7O3.C25H30N6O3.C24H29N7O3.C23H25F3N6O2.C22H26N6O2/c1-31(2)25(33)21-15-23(29-16-28-21)30-17-3-5-19(6-4-17)35-22-14-18(32-9-11-34-12-10-32)13-20-24(22)27-8-7-26-20;1-26-25(32)21-7-4-18(16-29-21)30-17-2-5-20(6-3-17)34-23-15-19(31-10-12-33-13-11-31)14-22-24(23)28-9-8-27-22;1-25-24(32)20-14-22(29-15-28-20)30-16-2-4-18(5-3-16)34-21-13-17(31-8-10-33-11-9-31)12-19-23(21)27-7-6-26-19;24-23(25,26)20-13-30-21(14-29-20)31-15-1-3-17(4-2-15)34-19-12-16(32-7-9-33-10-8-32)11-18-22(19)28-6-5-27-18;1-3-19(4-2-16(1)27-17-5-6-25-26-15-17)30-21-14-18(28-9-11-29-12-10-28)13-20-22(21)24-8-7-23-20/h7-8,13-17,19H,3-6,9-12H2,1-2H3,(H,28,29,30);4,7-9,14-17,20,30H,2-3,5-6,10-13H2,1H3,(H,26,32);6-7,12-16,18H,2-5,8-11H2,1H3,(H,25,32)(H,28,29,30);5-6,11-15,17H,1-4,7-10H2,(H,30,31);5-8,13-16,19H,1-4,9-12H2,(H,25,27).
What are the key properties of N,N-dimethyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-methyl-5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyridine-2-carboxamide;N-methyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyrazin-2-amine?
N,N-dimethyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-methyl-5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyridine-2-carboxamide;N-methyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyrazin-2-amine has a molecular weight of 2284.64 g/mol, XLogP of 15.34, 28 rotatable bonds, 7 hydrogen bond donors, and 42 hydrogen bond acceptors.
Where does this data come from?
All data for N,N-dimethyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-methyl-5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyridine-2-carboxamide;N-methyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyrimidine-4-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyridazin-4-amine;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyrazin-2-amine is sourced from PubChem (CID 158381264), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).